Impact of metformin, statins, and beta blockers on survival in patients with primary ovarian cancer: combined analysis of four prospective trials of AGO-OVAR and ENGOT/GCIG collaborators
Dominik Denschlag*, Florian Heitz, Jacobus Pfisterer, Darja Tutschkow, Alexander Reuss, Werner Meier, Philipp Harter, Pauline Wimberger, Mansoor Raza Mirza, Isabelle Ray-Coquard, Giovanni Scambia, Jae-Weon Kim, Nicoletta Colombo, Ana Oaknin, Jalid Sehouli, Kristina Lindemann, Coriolan Lebreton, Michael Eichbaum, Stefan Spiegelberg, Hannah WoopenAndreas du Bois
Dyk ned i forskningsemnerne om 'Impact of metformin, statins, and beta blockers on survival in patients with primary ovarian cancer: combined analysis of four prospective trials of AGO-OVAR and ENGOT/GCIG collaborators'. Sammen danner de et unikt fingeraftryk.